Fabtech Technologies vs Peers
- Market cap
- ₹636 crore
- P/E
- 13.1
- P/B
- 3.20
- ROE
- 16.4%
- Dividend yield
- 0.42%
Fabtech Technologies ranks 3rd by market capitalisation among 4 Medical Equipment & Supplies companies tracked by ATS. Its largest peers are Poly Medicure, Fischer Medical Ventures and GKB Ophthalmics. Its P/E of 13.1 compares with a peer median of 52.5.
Fabtech Technologies vs Medical Equipment & Supplies peers
Sorted by market capitalisation.
| Company | Close (₹) | 1D | Market cap (₹ cr) | P/E | P/B | ROE | 1Y return |
|---|---|---|---|---|---|---|---|
| Poly Medicure | 1,625.00 | -0.54% | 16,471 | 52.5 | 5.30 | 11.3% | +12.5% |
| Fischer Medical Ventures | 32.63 | -1.54% | 2,136 | 68.6 | 5.56 | 8.6% | +12.5% |
| Fabtech Technologies | 143.03 | +1.41% | 636 | 13.1 | 3.20 | 16.4% | — |
| GKB Ophthalmics | 61.50 | -0.42% | 31 | 9.6 | 0.59 | 2.3% | +12.5% |
Source: NSE end-of-day prices; ratios from company filings. Data as of 7 October 2026. How this data is compiled.
Fabtech Technologies peer comparison — frequently asked questions
Who are Fabtech Technologies' competitors?
Fabtech Technologies' listed peers in Medical Equipment & Supplies include Poly Medicure, Fischer Medical Ventures and GKB Ophthalmics, ranked here by market capitalisation.
How does Fabtech Technologies' P/E compare with its peers?
Fabtech Technologies trades at a P/E of 13.1, against a median of 52.5 across the 3 Medical Equipment & Supplies peers shown.
Which is the largest company among Fabtech Technologies' peers?
By market capitalisation, the largest company in the group is Poly Medicure at ₹16,471 crore, against ₹636 crore for Fabtech Technologies.
Same Data For Peers
Trade Fabtech Technologies With ATS
Track FABTECH live and place orders from the Pocket app or the Pocket Web terminal with an ATS trading and demat account.
Figures are for information only and are not investment advice or a recommendation to buy, sell or hold any security. Investments in securities are subject to market risks; read all related documents carefully before investing.